Weekly News Amount
Total
${lastRankDetail.pages.length}
Financing ${lastRankDetail.financing_pages.length}
Product ${lastRankDetail.product_pages.length}
Negative ${lastRankDetail.sentiment_pages.length}
ming-med is a platform-based headquarters enterprise guided by First-in-class medical innovation, highlighting the medical research and development capabilities of outstanding Chinese scientists and outstanding experts from China and the United States. The product pipeline of ming-med Medicine and its subordinate enterprises covers ophthalmic drugs, small molecule immune drugs, cell therapy, new medical beauty and pet drugs. The core R&D team includes five national distinguished experts, one national outstanding expert and many outstanding experts from China and the United States, and is researching more than ten kinds of products, most of which are competitive breakthrough First-in-class drugs, and the main products have completed preliminary research and development or realized productization

Signals

Events ${currentEventsPage.count} Events
Events (${currentEventsPage.count}) Date
Nothing Happens :-(
${e.desp} ${e.date}
News ${ rankDetail.pages.length } News Articles ${currentTimeRange.start} ~ ${currentTimeRange.end}
Article (${rankDetail.pages.length}) Tag
${article.en_title} ${article.tag}
Industry Financing Info

Research

Intelligence 0 Research Briefs

Competition

Competitors 0 Competitors